Acquisition Announced Sponsor buyer
Gannet BioChem acquisition of Laysan Bio
Announced 17 Feb 2026
Advisers
Laysan Bio
Target
Not disclosed
Gannet BioChem
Acquirer
- Legal adviser
- Goodwin

Team: Jim Barrett, Eric Carlson, Jon Berke, Ryan Peloquin, Travis Salters, Shannyn Henke, Kelly Song, Jacob Margolis, Timothy Holahan, Austin Jones, Malhar Naik, Jacqueline Klosek, Richard Matheny, Gozde Guckaya, Andy Sucoff, Nate Brodeur, Daniel Karelitz, Nicole Brock, Matthew Wetzel, Julie Tibbets, Kerri Finn, Amanda Fernandes
- Target
- Laysan Bio
- Acquirer
- Gannet BioChem
- Sponsor
- Ampersand Capital Partners
- Target based in
- United States
- Buyer based in
- United States
- Sector
- Pharma Services
- Tags
- Pharma Services, Contract Manufacturing, Life Sciences
In the league tables
Similar deals
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- Everest Clinical Research acquisition of Firma Data Services Sep 2026 · Clinical Trial Services
- Kincell Bio and Cellipont Bioservices merger Sep 2026 · Pharma Services
- VION acquisition of Prolytix Sep 2026 · Pharma Services
- McKesson acquisition of Precision Medicine Group Aug 2026 · US$2.3bn · Clinical Trial Services
Sources
- 17 Feb 2026 Goodwin Guides Gannet BioChem on Acquisition of Laysan Bio goodwinlaw.com